ad image

BioMarin

1 / 1
BioMarin Going for 2020 Approval of its Hemophilia A Gene Therapy
Drug Approval

BioMarin Going for 2020 Approval of its Hemophilia A Gene Therapy

David Alvaro, Ph.D.

Pharma's Almanac

PAO-M08-19-NI-026Aug 22, 2019
BioMarin
Positive Opinion

BioMarin Receives Positive CHMP Opinion in Europe for Palynziq® (pegvaliase Injection) for Treatment of Patients with Phenylketonuria (PKU) Aged 16 and Older

BioMarin

PR-M03-19-NI-008Mar 04, 2019
BioMarin
Clinical Trials

BioMarin Doses First Participant in Phase 2 Study of Vosoritide for Treatment of Infants and Young Children with Achondroplasia

BioMarin

PR-M06-18-NI-059Jun 18, 2018
Results of New Gene Therapy Revealed at Hemophilia Meeting
Hemophilia

Results of New Gene Therapy Revealed at Hemophilia Meeting

Nice Insight

PAO-M12-17-NI-017Dec 12, 2017
BioMarin Highlights Advanced Genetic Disease Therapy Pipeline
FDA

BioMarin Highlights Advanced Genetic Disease Therapy Pipeline

Nice Insight

PAO-M10-17-NI-035Oct 24, 2017
1 / 1